newsletter

Daraxonrasib nearly doubled median survival in previously treated metastatic pancreatic cancer. For Dr Eileen O’Reilly, the result is not simply a remarkable curve on a conference screen, but the beginning of a new way to think about a disease long…

Over four decades, Dr Tezer Kutluk, Scientific Director of Medicana Health group and Chair of the Department of Pediatric Oncology at Medicana Hospitals, Turkey, has witnessed the transformation of cancer care—from the early days of pediatric oncology to the era…

Pancreatic ductal adenocarcinoma remains one of the most difficult cancers to treat, with limited progress in drug development over the past decade. At the 2026 ASCO Annual Meeting, the Phase 3 RASolute 302 trial delivered results that stood out against…

How Professor Nagi El Saghir Changed the Language of Cancer in the Middle East and Helped Redefine Global Oncology The airport in Beirut looked very different in 1971. Families walked all the way to the aircraft. Parents accompanied their children…

“Tax planning was one major reason for the foundation of Elekta.” Larry Leksell says it with a smile that suggests he enjoys disrupting the mythology people create around founders. Most people expect a grand story of origin. A visionary revelation.…

We often describe progress in oncology through the language of innovation. New drugs. New technologies. New discoveries. Yet scientific breakthroughs rarely change cancer care on their own. They require people willing to pursue difficult ideas, build institutions, challenge accepted thinking,…

Five trials, five cancers, and what the ASCO 2026 plenary really promised patients ASCO 2026’s plenary delivered five real advances across five cancers, and a standing ovation that pulled a hall full of oncologists to their feet. The harder question…

On paper, cancer care can be mapped, measured, and modelled. In practice, it is far less contained. For Charis Ng, a trainee health psychologist and PhD student, that gap between theory and lived reality became impossible to ignore during her…

On World Cancer Day, Commissioners Várhelyi and Albuquerque reaffirmed the European Commission’s commitment to the right to be forgotten for cancer survivors. Yet their announcement of non-binding guidance to financial institutions in 2026 falls significantly short of what survivors and…

From crowded oncology wards in Cairo to international leadership in cancer education, Dr. Mohamed Emam Sobeih has built a career shaped by one central belief: treating cancer requires more than medicine alone. At the National Cancer Institute Egypt, where Dr…